WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s share price was up 6.8% during mid-day trading on Wednesday . The company traded as high as $13.14 and last traded at $14.17. Approximately 465 shares traded hands during mid-day trading, a decline of 51% from the average daily volume of 948 shares. The stock had previously closed at $13.26.
WisdomTree BioRevolution Fund Stock Performance
The stock’s 50-day moving average price is $13.95 and its 200-day moving average price is $13.43. The company has a market capitalization of $2.12 million, a price-to-earnings ratio of 17.03 and a beta of 1.01.
Hedge Funds Weigh In On WisdomTree BioRevolution Fund
An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC boosted its position in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 21.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,908 shares of the company’s stock after buying an additional 2,774 shares during the quarter. Jane Street Group LLC owned approximately 10.61% of WisdomTree BioRevolution Fund worth $229,000 at the end of the most recent quarter.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
See Also
- Five stocks we like better than WisdomTree BioRevolution Fund
- Why Invest in High-Yield Dividend Stocks?
- Lowe’s Builds Value for Investors: Still a Good Buy in 2025
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Jackson Hole 2025: Fed’s Signal Could Shift Stocks Fast
- Overbought Stocks Explained: Should You Trade Them?
- Rocket Lab Stock: Breakout Brewing or Time for Patience?
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.